Articaine Hydrochloride with Adrenaline
Articaine hydrochloride 40mg/ml, adrenaline 1 in 100,000 (10 micrograms/ml), 2.2ml cartridge for dental use
Cocaine HCl (Solution 10% w/v)
Sterile oromucosal solution 10%
For topical use only. Not for injection or to be taken.
Cocaine Hydrochloride Solution is indicated to provide local anaesthesia and vasoconstriction of accessible mucous membranes prior to surgery especially in the oral, laryngeal, and nasal cavities.
Ethyl Chloride (Spray)
CAUTION: Extremely flammable liquified gas under pressure. Stable at room temperature 8ºC-20ºC. Use only with good ventilation. Avoid use near electrical equipment, naked flames or high temperature surfaces. Store in a metal cupboard in a ventilated room- never in a refridgerator. All empty or unused containers must be returned to pharmacy for destruction.
Ropivacaine hydrochloride (Injection)
2mg/ml, 7.5mg/ml or 10mg/ml
Cocaine 5% with adrenaline 1:2000 (Topical gel)
GWH A&E only
Non Formulary Items
Benzocaine 20% Gel
(Ultracare® Bubble Gum)
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
High Cost Drug Approval System
Traffic Light Status Information
RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.
Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.
Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.
Suitable for patient to be directed to buy themselves
Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.
(In use from Oct 2020) Used where a decision has been made by the BSW APC not to routinely commission this preparation for its licensed indications. Do not prescribe.
Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.